Karen J. Wilson has served as a member of our board of directors since August 2020. Ms. Wilson has more than 30 years of industry and leadership experience in life sciences companies across finance, strategy, and risk management. She currently serves as independent director and audit committee chair for Angion Biomedica, Connect Biopharma, and LAVA Therapeutics. Ms. Wilson served as senior vice president of finance at Jazz Pharmaceuticals plc until September 2020 after serving as vice president of finance and principal accounting officer. Prior to Jazz, Ms. Wilson was the vice president of finance and principal accounting officer for PDL BioPharma, Inc. She also held senior roles in finance and operations with ViroLogic, Inc. and Novare Surgical Systems, Inc. She is a Certified Public Accountant and holds a bachelor’s degree in business from the University of California, Berkeley.